COYA THERAPEUTICS INC(COYA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

COYA COYA THERAPEUTICS INC

交易中 02-11 11:21:46 EST

4.90

-0.06

-1.21%

最高5.01	最低4.77	成交量5.87万
今开5.00	昨收4.96	日振幅4.94%
总市值1.03亿	流通市值8,247万	总股本2,092万
成交额28.87万	换手率0.35%	流通股本1,683万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"COYA","market":"US","secType":"STK","nameCN":"COYA THERAPEUTICS INC","latestPrice":4.9,"timestamp":1770826840869,"preClose":4.96,"halted":0,"volume":58676,"delay":0,"changeRate":-0.012096774193548309,"floatShares":16831400,"shares":20924500,"eps":-1.108176,"marketStatus":"交易中","change":-0.06,"latestTime":"02-11 11:21:46 EST","open":5,"high":5.01,"low":4.765,"amount":288699.3802744,"amplitude":0.049395,"askPrice":4.92,"askSize":300,"bidPrice":4.85,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-1.108176,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"listingDate":1672290000000,"exchange":"NASDAQ","adjPreClose":4.96,"preHourTrading":{"tag":"盘前","latestPrice":4.96,"preClose":4.96,"latestTime":"08:40 EST","volume":137,"amount":679.52,"timestamp":1770817242725,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":4.96,"preClose":4.96,"latestTime":"16:10 EST","volume":5,"amount":24.8,"timestamp":1770757805136,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.256874,"impliedVol":1.5056,"impliedVolPercentile":0.7092},"requestUrl":"/m/hq/s/COYA/wiki","defaultTab":"wiki","newsList":[{"id":"1143762138","title":"COYA THERAPEUTICS INC公布研究者发起研究结果：低剂量IL-2与CTLA4-Ig联合疗法展现增强调节性T细胞功能及稳定额颞叶痴呆患者认知能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1143762138","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143762138?lang=zh_cn&edition=full","pubTime":"2026-01-08 21:03","pubTimestamp":1767877381,"startTime":"0","endTime":"0","summary":"COYA THERAPEUTICS INC宣布了一项由研究者发起的研究成果。该研究聚焦于低剂量IL-2（Ld Il-2）与CTLA4-Ig联合疗法在额颞叶痴呆患者中的应用。\n研究数据表明，该疗法能够有效增强调节性T细胞的功能。同时，在治疗过程中，患者的认知能力表现出稳定性。这一结果为相关疾病的治疗提供了新的潜在方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"1126083201","title":"COYA THERAPEUTICS INC宣布美国FDA受理其治疗额颞叶痴呆症的新药临床试验申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1126083201","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126083201?lang=zh_cn&edition=full","pubTime":"2026-01-05 21:03","pubTimestamp":1767618193,"startTime":"0","endTime":"0","summary":"COYA THERAPEUTICS INC宣布，其针对额颞叶痴呆症（FTD）的候选药物Coya 302，其研究性新药（IND）申请已获得美国食品药品监督管理局（FDA）的正式受理。这一关键进展标志着该药物向临床开发阶段迈出了重要一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"1164854935","title":"Coya Therapeutics 获得加拿大卫生部临床试验申请接受，用于推进针对肌萎缩侧索硬化症的 Coya 302 Alstars 试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1164854935","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164854935?lang=zh_cn&edition=full","pubTime":"2025-12-23 21:02","pubTimestamp":1766494968,"startTime":"0","endTime":"0","summary":"Coya Therapeutics 获得加拿大卫生部的临床试验申请（CTA）批准，可以推进 Coya 302 Alstars 试验，以治疗肌萎缩侧索硬化症（ALS）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"1160199370","title":"Coya Therapeutics宣布患者已在Alstars试验中接受Coya 302治疗ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=1160199370","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160199370?lang=zh_cn&edition=full","pubTime":"2025-12-09 21:03","pubTimestamp":1765285436,"startTime":"0","endTime":"0","summary":"Coya Therapeutics宣布患者已在Alstars试验中接受Coya 302治疗ALS","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"2586491008","title":"Coya Therapeutics, Inc.盘中异动 早盘股价大涨5.18%报6.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586491008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586491008?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:13","pubTimestamp":1763997213,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时13分，Coya Therapeutics, Inc.股票出现异动，股价大幅拉升5.18%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Pasithea Therapeutics Corp C/Wts 12/08/2026 、Enlivex Therapeutics Ltd.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Osr Holdings, Inc.较为活跃，换手率分别为599.38%、449.42%、67.36%，振幅较大的相关个股有Enlivex Therapeutics Ltd.、Pasithea Therapeutics Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为47.95%、39.27%、30.30%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124231333977cbb15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124231333977cbb15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","COYA","BK4139","BK4007"],"gpt_icon":0},{"id":"1157488428","title":"Coya Therapeutics宣布完成研究者发起的开放标签研究患者入组，该研究采用低剂量IL-2和CTLA4-Ig联合疗法治疗轻度至中度额颞叶痴呆患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1157488428","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157488428?lang=zh_cn&edition=full","pubTime":"2025-09-29 20:03","pubTimestamp":1759147423,"startTime":"0","endTime":"0","summary":"Coya Therapeutics宣布完成研究者发起的开放标签研究患者入组，该研究采用低剂量IL-2和CTLA4-Ig联合疗法治疗轻度至中度额颞叶痴呆患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"1124423886","title":"COYA THERAPEUTICS INC的Coya 303在临床前动物炎症模型中显示出良好的中枢神经系统抗炎效果和系统性调节性T细胞增强效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1124423886","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124423886?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:10","pubTimestamp":1758024614,"startTime":"0","endTime":"0","summary":"COYA THERAPEUTICS INC的Coya 303在临床前动物炎症模型中显示出良好的中枢神经系统抗炎效果和系统性调节性T细胞增强效果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"1196672752","title":"COYA THERAPEUTICS INC于8月29日从DR. Reddy's Laboratories Ltd获得420万美元里程碑付款 - SEC申报文件","url":"https://stock-news.laohu8.com/highlight/detail?id=1196672752","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196672752?lang=zh_cn&edition=full","pubTime":"2025-09-02 20:35","pubTimestamp":1756816516,"startTime":"0","endTime":"0","summary":"COYA THERAPEUTICS INC于8月29日从DR. Reddy's Laboratories Ltd获得420万美元里程碑付款 - SEC申报文件","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","COYA"],"gpt_icon":0},{"id":"1123161223","title":"美国FDA接受COYA THERAPEUTICS INC渐冻症疗法申请后，该公司股价盘前上涨4.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123161223","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123161223?lang=zh_cn&edition=full","pubTime":"2025-08-25 20:35","pubTimestamp":1756125319,"startTime":"0","endTime":"0","summary":"美国FDA接受COYA THERAPEUTICS INC渐冻症疗法申请后，该公司股价盘前上涨4.7%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["COYA","BK4139"],"gpt_icon":0},{"id":"2518927908","title":"Coya Therapeutics, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518927908","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518927908?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:01","pubTimestamp":1741618889,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时01分，Coya Therapeutics, Inc.股票出现异动，股价急速下跌5.09%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。其相关个股中，Checkpoint Therapeutics, Inc.、Mineralys Therapeutics, Inc.、Trevi Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Aeon Biopharma, Inc.较为活跃，换手率分别为3515.12%、785.24%、775.66%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Scisparc Ltd.、Dogwood Therapeutics, Inc.，振幅分别为111.00%、46.90%、41.36%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230129abf31dd5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310230129abf31dd5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2516367788","title":"Coya Therapeutics, Inc.盘中异动 早盘急速跳水5.25%报7.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516367788","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516367788?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:42","pubTimestamp":1741099351,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时42分，Coya Therapeutics, Inc.股票出现异动，股价急速下挫5.25%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1119.68%、1103.84%、458.66%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为37.67%、22.25%、21.85%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224232a25f0816&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224232a25f0816&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2514401320","title":"Coya Therapeutics, Inc.盘中异动 早盘股价大跌6.24%报6.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514401320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514401320?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:43","pubTimestamp":1740753828,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时43分，Coya Therapeutics, Inc.股票出现波动，股价快速跳水6.24%。截至发稿，该股报6.31美元/股，成交量784股，换手率0.00%，振幅0.00%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224348abe0edf7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228224348abe0edf7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2505720892","title":"D. Boral Capital：维持Coya Therapeutics(COYA.US)评级，由买入调整至买入评级, 目标价由15.00美元调整至15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2505720892","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505720892?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:01","pubTimestamp":1737471718,"startTime":"0","endTime":"0","summary":"D. Boral Capital：维持Coya Therapeutics(COYA.US)评级，由买入调整至买入评级, 目标价由15.00美元调整至15.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/21230147677719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["COYA","LENZ"],"gpt_icon":0},{"id":"2485260564","title":"Coya Therapeutics, Inc.盘中异动 急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485260564","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485260564?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:30","pubTimestamp":1732289458,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时30分，Coya Therapeutics, Inc.股票出现异动，股价快速拉升5.10%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.45%。其相关个股中，Replimune Group, Inc.、Invizyne Technologies Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1630.40%、112.61%、82.51%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为62.01%、45.86%、38.02%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122233058abd7ac09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122233058abd7ac09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","COYA"],"gpt_icon":0},{"id":"2484504676","title":"Coya Therapeutics, Inc.盘中异动 早盘股价大涨6.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484504676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484504676?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:35","pubTimestamp":1731940530,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时35分，Coya Therapeutics, Inc.股票出现波动，股价大幅上涨6.65%。截至发稿，该股报6.74美元/股，成交量4455股，换手率0.03%，振幅3.48%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822353098e433eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822353098e433eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","COYA"],"gpt_icon":0},{"id":"2483004390","title":"Coya Therapeutics, Inc.2024财年第三财季实现净利润-4.02百万美元，同比减少17.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483004390","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483004390?lang=zh_cn&edition=full","pubTime":"2024-11-13 13:00","pubTimestamp":1731474045,"startTime":"0","endTime":"0","summary":"11月13日，Coya Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-4.02百万美元，同比减少17.54%；其中营业收入为0.00美元，每股基本收益为-0.26美元。从资产负债表来看，Coya Therapeutics, Inc.总负债3.54百万美元，其中短期债务0.00美元，资产负债比为10.05，流动比率为15.31。机构评级：截至2024年11月13日，当前有5家机构对Coya Therapeutics, Inc.目标价做出预测，其中目标均价为15.90美元，其中最低目标价为14.00美元，最高目标价为18.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113130053a2327911&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113130053a2327911&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA"],"gpt_icon":0},{"id":"2479331380","title":"Coya Therapeutics, Inc.盘中异动 早盘股价大跌5.94%报6.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479331380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479331380?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:52","pubTimestamp":1730382761,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时52分，Coya Therapeutics, Inc.股票出现波动，股价快速跳水5.94%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为2.40%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Aerovate Therapeutics, Inc.涨幅较大，Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃，换手率分别为212.20%、204.45%、153.43%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025，振幅分别为39.30%、28.17%、21.99%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215241971a38cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031215241971a38cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2479288242","title":"Coya Therapeutics, Inc.盘中异动 早盘股价大跌11.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288242?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:32","pubTimestamp":1730208759,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时32分，Coya Therapeutics, Inc.股票出现异动，股价大幅下挫11.58%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Lixte Biotechnology Holdings, Inc.涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为521.18%、249.38%、131.22%，振幅较大的相关个股有Glycomimetics, Inc.、Entero Therapeutics Inc.、Sangamo Therapeutics, Inc.，振幅分别为22.06%、11.54%、10.29%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921323995bd821b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102921323995bd821b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0},{"id":"2478648131","title":"Coya Therapeutics, Inc.盘中异动 早盘大幅拉升5.47%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478648131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478648131?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:02","pubTimestamp":1730124146,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时02分，Coya Therapeutics, Inc.股票出现波动，股价急速拉升5.47%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028220226a1f25e2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028220226a1f25e2c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["COYA","LENZ","BK4139"],"gpt_icon":0},{"id":"2478953583","title":"Coya Therapeutics, Inc.盘中异动 临近午盘股价大跌5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478953583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478953583?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:49","pubTimestamp":1729871355,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时49分，Coya Therapeutics, Inc.股票出现波动，股价快速跳水5.15%。Coya Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Immunitybio, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为804.51%、737.67%、218.60%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Iterum Therapeutics Plc、Elevai Labs, Inc.，振幅分别为91.58%、90.60%、85.14%。Coya Therapeutics, Inc.公司简介：Coya Therapeutics Inc 是一家临床阶段的生物技术公司，专注于开发专有医药产品以调节调节性 T 细胞的功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025234915ab744458&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025234915ab744458&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","COYA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.coyatherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0206},{"period":"1month","weight":0.0227},{"period":"3month","weight":-0.1856},{"period":"6month","weight":-0.1275},{"period":"1year","weight":-0.2791},{"period":"ytd","weight":-0.1448}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Coya Therapeutics, Inc.根据特拉华州法律注册成立。该公司是一家临床阶段生物技术公司，专注于开发专利药物，以调节性T细胞的功能。Tregs是由抑制炎症反应的CD4+CD25高hFOXP3+细胞组成的T淋巴细胞亚群。Tregs及其转录因子通过调节自身免疫和炎症反应以及维持哺乳动物的自我耐受，对维持体内平衡至关重要。Treg功能障碍是严重神经退行性疾病、自身免疫疾病和代谢疾病的病理生理学中的重要组成部分，该公司认为迫切需要新的有效治疗方法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.110734},{"month":2,"riseRate":0.75,"avgChangeRate":0.178876},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.003533},{"month":4,"riseRate":0.666667,"avgChangeRate":0.047977},{"month":5,"riseRate":0,"avgChangeRate":-0.140621},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.071803},{"month":7,"riseRate":0.666667,"avgChangeRate":0.048228},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.043845},{"month":9,"riseRate":0.666667,"avgChangeRate":0.008791},{"month":10,"riseRate":1,"avgChangeRate":0.152956},{"month":11,"riseRate":0.666667,"avgChangeRate":0.020366},{"month":12,"riseRate":0.333333,"avgChangeRate":0.053338}],"exchange":"NASDAQ","name":"COYA THERAPEUTICS INC","nameEN":"COYA THERAPEUTICS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"COYA THERAPEUTICS INC(COYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供COYA THERAPEUTICS INC(COYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"COYA THERAPEUTICS INC,COYA,COYA THERAPEUTICS INC股票,COYA THERAPEUTICS INC股票老虎,COYA THERAPEUTICS INC股票老虎国际,COYA THERAPEUTICS INC行情,COYA THERAPEUTICS INC股票行情,COYA THERAPEUTICS INC股价,COYA THERAPEUTICS INC股市,COYA THERAPEUTICS INC股票价格,COYA THERAPEUTICS INC股票交易,COYA THERAPEUTICS INC股票购买,COYA THERAPEUTICS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"COYA THERAPEUTICS INC(COYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供COYA THERAPEUTICS INC(COYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}